Market by Procedure (Laparoscopy, Orthopedic Surgery, Cardiovascular, Obstetrics and Gynecology, Wound Closure, Plastic & Reconstructive Surgery, Thoracic Surgery, Microvascular, Urology, Neurosurgery, Other Procedures) Type of Infection (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI) Industry Vertical (Hospitals, Ambulatory Surgical Centers) Product (Disinfectants, Manual Reprocessors Solutions, Surgical Drapes, Surgical Gloves, Skin Preparation Solutions, Surgical Irrigation, Surgical Scrubs, Hair Clippers, Medical Nonwovens, Other Products) and Country Outlook | Forecast 2024-2032
Triton’s research report suggests that the North America surgical site infection control market is predicted to register growth in terms of revenue at a CAGR of 5.02% during the forecast period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
In North America, the surgical site infection control market is supported by increased awareness of the critical need to prevent infections in healthcare settings. According to the Centers for Disease Control and Prevention (CDC), SSIs are among the most common healthcare-associated infections (HAIs). This has spurred numerous initiatives and regulatory measures to enhance infection control practices. Furthermore, the US Department of Health and Human Services’ National Action Plan to Prevent Health Care-Associated Infections sets ambitious targets for reducing SSIs. Additionally, the implementation of stringent guidelines by bodies like the Association for Professionals in Infection Control and Epidemiology (APIC) has heightened the focus on preventive measures, thereby expanding the market's scope.
The countries analyzed in this region comprise:
The United States spearheads the region’s market, gaining $1938.3 million in 2023
As per the CDC, around 500,000 surgical site infections are recorded in the US yearly. The rising number of surgical procedures, particularly among an aging population, is driving the demand for advanced SSI control measures.
The US government, through organizations like the Centers for Medicare & Medicaid Services (CMS), has implemented various policies to reduce SSIs, including financial penalties for hospitals with high infection rates.
This has led to increased adoption of SSI prevention technologies and practices, such as antimicrobial sutures, advanced wound dressings, and sterilization equipment. Additionally, the FDA has been actively involved in approving new technologies, which is expected to further boost the studied market.
Market Forecast for Canada
The surgical site infection (SSI) control market in Canada is supported by the rising number of surgical procedures and heightened awareness of infection control measures. Surgical site infections are a significant concern in Canadian healthcare, with reports indicating that SSIs frequently lead to complications such as readmissions and revision surgeries, contributing to a substantial financial and resource burden on the healthcare system. Besides, government initiatives and collaborations between public and private entities have played a crucial role in supporting the surgical site infection control market.
The market segmentation comprises procedure, industry vertical, type of infection, and product. The type of infection section includes deep incisional, organ or space, and superficial incisional SSI.
Deep incisional surgical site infections (SSIs) are infections that occur beneath the incision area, involving deeper soft tissues, and can lead to serious complications if not properly managed. These infections typically arise within 30 days post-surgery and can result from contamination during surgery or poor post-operative care. To mitigate the risk of deep incisional SSIs, the use of surgical site infection control products, such as antimicrobial dressings, incision drapes, and infection-resistant sutures, is crucial. These products help reduce microbial contamination, promote a sterile environment, and facilitate proper wound healing, thereby lowering the incidence of SSIs and improving patient outcomes.
Contender Analysis in the Surgical Site Infection Control Market:
Kimberly-Clark Corporation, an American multinational company, specializes in producing consumer goods, primarily paper-based products. Headquartered in the United States, its operations are organized into three main segments: consumer tissue, personal care, and K-C Professional. The personal care segment focuses on manufacturing and marketing disposable diapers, training pants, swim pants, baby wipes, and products for feminine hygiene and incontinence care. The K-C Professional segment provides wipers, tissue, towels, apparel, soaps, and sanitizers for commercial use. Founded in 1872, Kimberly-Clark has established itself as a leader in its industry, offering a wide range of essential products for consumers and businesses alike.
Other companies thriving in the surgical site infection control market include Johnson & Johnson, Sotera Health LLC, Steris Corporation, and Kimberly-Clark Corporation.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the surgical site infection control market revenue growth in North America and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the NA surgical site infection control market’s growth during the upcoming years
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT
ANALYSIS ON THE SURGICAL SITE INFECTION CONTROL MARKET
2.1.1. COVID-19
IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. KEY
MARKET STRATEGIES
2.3.1. PRODUCT
LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS
DIVESTITURES & EXPANSIONS
2.4. MARKET
DRIVERS
2.4.1. ESCALATING
INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
2.4.2. GROWING
GERIATRIC POPULATION
2.4.3. REGULATORY
GUIDELINES FOR PREVENTING HOSPITAL-ACQUIRED INFECTION
2.5. MARKET
CHALLENGES
2.5.1. INCREASE
IN OUTPATIENT TREATMENT UTILIZATION
2.5.2. SURGE
IN MEDICAL WASTE DUE TO THE USE OF DISPOSABLE MEDICAL ITEMS
2.5.3. INSUFFICIENT
AWARENESS REGARDING HOSPITAL-ACQUIRED INFECTIONS
2.6. MARKET
OPPORTUNITIES
2.6.1. GROWTH
OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
2.6.2. RISE
IN SURGICAL PROCEDURE RATES
2.6.3. TECHNOLOGICAL
ADVANCEMENTS IN PREVENTING SURGICAL SITE INFECTIONS
2.7. ANALYST
PERSPECTIVE
3. NORTH
AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. NORTH
AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY TYPE OF INFECTION
4.1. SUPERFICIAL
INCISIONAL SSI
4.2. DEEP
INCISIONAL SSI
4.3. ORGAN
OR SPACE SSI
5. NORTH
AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
6. NORTH
AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY PRODUCT
6.1. DISINFECTANTS
6.1.1. SKIN
DISINFECTANTS
6.1.2. HAND
DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTIONS
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTIONS
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. NORTH
AMERICA SURGICAL SITE INFECTION CONTROL MARKET – BY COUNTRY OUTLOOK
7.1. NORTH
AMERICA
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. UNITED
STATES
7.1.1.1.1. UNITED
STATES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.2. CANADA
7.1.1.2.1. CANADA
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AMERICAN
POLYFILM INC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. 3M
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. ANSELL
LIMITED
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. BELIMED
LIFE SCIENCE AG
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. BECTON,
DICKINSON AND COMPANY (BD)
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. BIOMERIEUX
SA
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. GETINGE
AB
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. GAMA
HEALTHCARE
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. JOHNSON
& JOHNSON
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. SOTERA
HEALTH LLC
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. KIMBERLY-CLARK
CORPORATION
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. KEY
CHALLENGES
8.12. STERIS
CORPORATION
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. STRYKER
CORPORATION
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE 2: LIST OF PRODUCT
LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 5: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $
MILLION)
TABLE 7: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE 8: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 9: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2023 & 2032 (IN %)
FIGURE 3: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $
MILLION)
FIGURE 4: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $
MILLION)
FIGURE 5: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $
MILLION)
FIGURE 6: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032
(IN $ MILLION)
FIGURE 7: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $
MILLION)
FIGURE 8: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE
SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $
MILLION)
FIGURE 10: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $
MILLION)
FIGURE 11: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $
MILLION)
FIGURE 12: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $
MILLION)
FIGURE 13: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $
MILLION)
FIGURE 14: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2023 & 2032
(IN %)
FIGURE 15: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI,
2024-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $
MILLION)
FIGURE 17: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $
MILLION)
FIGURE 18: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2023 & 2032
(IN %)
FIGURE 19: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS,
2024-2032 (IN $ MILLION)
FIGURE 21: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 22: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $
MILLION)
FIGURE 23: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2023 & 2032 (IN
%)
FIGURE 24: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $
MILLION)
FIGURE 25: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $
MILLION)
FIGURE 26: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS,
2024-2032 (IN $ MILLION)
FIGURE 27: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $
MILLION)
FIGURE 28: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $
MILLION)
FIGURE 29: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS,
2024-2032 (IN $ MILLION)
FIGURE 30: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $
MILLION)
FIGURE 31: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $
MILLION)
FIGURE 32: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $
MILLION)
FIGURE 33: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $
MILLION)
FIGURE 34: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $
MILLION)
FIGURE 35: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN
%)
FIGURE 36: UNITED STATES
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: CANADA SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)